2 assets in Becker Muscular Dystrophy

Therapeutic assets addressing Becker Muscular Dystrophy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Sevasemten Becker Muscular Dystrophy	Edgewise Therapeutics, Inc.	P2	B (60)
Vamorolone Becker Muscular Dystrophy	ReveraGen BioPharma, Inc.	P2	B (57)